SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-027942
Filing Date
2022-05-18
Accepted
2022-05-18 16:15:52
Documents
15
Period of Report
2022-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160227-8k425_biotech.htm   iXBRL 8-K 43528
2 PRESS RELEASE ea160227ex99-1_biotech.htm EX-99.1 38760
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3018
  Complete submission text file 0001213900-22-027942.txt   328729

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biotu-20220518.xsd EX-101.SCH 4129
5 XBRL DEFINITION FILE biotu-20220518_def.xml EX-101.DEF 27485
6 XBRL LABEL FILE biotu-20220518_lab.xml EX-101.LAB 37982
7 XBRL PRESENTATION FILE biotu-20220518_pre.xml EX-101.PRE 26103
9 EXTRACTED XBRL INSTANCE DOCUMENT ea160227-8k425_biotech_htm.xml XML 7006
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39935 | Film No.: 22939284
SIC: 2834 Pharmaceutical Preparations